(ü 248) |
|
|
|
|
[] GCɾ, -, コɾ
Ʈ , GCɾ(ǥ ȿ) ࡤ コɾ ߴٰ 26 . GCɾ コɾ Ͽ コɾ ϴ ̹ ó̴.
Ȳ
2023-07-26
|
|
|
|
|
[] GCڿ, Ŀ ż
GCڿ(ǥ ) 24 ڻ Ŀ żϱ ߴٰ 25 . GCڿ 2忡 Ŀ żϱ ߴ. ̴ 2
Ȳ
2023-07-25
|
|
|
|
|
[] ǽ, 캴 AB ӻ 2b
(Centessa Pharmaceuticals) ڻ 캴 ġ ǽ(SerpinPC) ȿ ϴ ӻ 2b ۵Ǿٰ . PRESent-2(NCT05789524) ̸ ٿ
Ȳ
2023-07-25
|
|
|
|
|
[] "캴 ġ ٲ㵵 ü ʾ" ״
ֱ , 캴A ȯڰ ġ ٸ ǰ ȯص 8ڿ ȭ ü ʴ´ٴ . ̴ ġ ص ȯ 鿪 ̳ ġ ȿɿ ġ ʴ´ٴ ǹ̿ ȯڿ
Ȳ
2023-07-23
|
|
|
|
|
[] GC, ȫ Ⳳΰû û
Ⳳΰû ȫ û ûGC(ǥ ӽ ) ȫ Ⳳΰû ûϿ ٶ Ư ǽߴٰ 7 . ȫ û ġ Źͽ(Security Go
Ȳ
2023-07-07
|
|
|
|
|
[] (ι°) 캴B ġ, ̱ û
ġ ǥ մ ִ , ̱ Ǿ 캴B ȯ ġḦ ȭ(Pfizer) ȸ 'Ǵٳ ĺ'(fidanacogene e
Ȳ
2023-07-07
|
|
|
|
|
[] WFH ε α, ī ձ
쿬(World Federation of Hemophilia, WFH) 3, ε α ī 湮Ͽ ϰ, ȯ ӿ ʿ ͵ ߴ.ε α ǥ
Ȳ
2023-07-05
|
|
|
|
|
[] GC, 9õ Ը
Ʈʻ IVIG-SN 5% ǰ 5Ⱓ GC(ǥ ö) 6 30 Ʈʻ (Blau Farmaceutica) ڻ 鿪۷κ ̺۷κҸ-(IVIG-SN 5%)
Ȳ
2023-07-04
|
|
|
|
|
[] GC, , ó
̳ ü ǰ ߽ ǰ ֽ ġ ǥθ ַ ȸ GC(ǥ ) 1 ƼŻ ĸ ȣڿ (Ī: Ƿ) Ȳ
Ȳ
2023-07-04
|
|
|
|
|
[] Ÿ, 캴A ġ FDA
ֱ 캴B ġ 'н' ۵Ǿٴ ҽ ̱ ǰǾ౹(FDA) 캴A ȸ ġ Ÿ(Roctavian, valoctocogene roxaparvov
Ȳ
2023-07-03
|
|
|
|
|
[] 캴 ƾ
B 캴 Ʈ(von Willebrand disease, VWD) ̸ ٸ 鿡 ʾҽϴ. ̷ ȯ ϰ ʾ ̷ Į 鿡 ؼ
Ȳ
2023-07-03
|
|
|
|
|
[] , 1⵿ 캴A Ҿȯ
پ 캴 ֻ ġ ӻ , 1ȸ ġ ǽ ִ ġ Ҿ ӻ迡 Ź ȿ ִ Ǿ. ӻ 3 迡 (Altuviiio, efanesoct
Ȳ
2023-07-01
|
|
|
|
|
|
|
[ Inside] GC, ISTH 2023 ȯ ǥ
ȯ 캴 ü ġ Ҽ ڹ ġ(GC1126A), ο ġ ɼ ͱ ǥ 캴 ġ ȸ GC(ǥ ö) 24~28 ij
Ȳ
2023-07-01
|
|
|
|
|
[] 캴B ġ 'н', ̱ ʷ
- ̱ ʷ ǸŵǴ 캴B ġ н- 2022 FDA ġ, 350 ( 45)CSL (CSL Behring) ̱ 캴B ȯ ΰ ִ ο ε ġ
Ȳ
2023-06-28
|
|
|
|
|
[] 'ȯ' 쿬(WFH), ߳
쿬(World Federation of Hemophilia) 1963 ij ũ (Frank Schnabel) ȸ ̷ ط 60ֳ ߴ. WFH ° ,
Ȳ
2023-06-27
|
|
|
|
|
[] 캴 ġ
1 ȿ ġḦ 캴A ȯڴ Ϲ ü ǰ Ͽ ǰ Ÿ. ڵ 츮 캴A ӻ ʰ ε
Ȳ
2023-06-26
|
|
|
|
|
[] ͽôƼ, 캴B 12 ̸ FDA û
̱ ǰǾ౹(FDA) 12 ̸ 캴 B Ҿƿ ͽôƼ(Ixinity, Ʈ볪ڱ ) û ϱ ߴ. ռ ͽôƼ 12 ̻ ûҳ FDA ִ. ġ
Ȳ
2023-06-26
|
|
|
|
|
[] ISTH 2023 ȸ, ij Ʈÿ
캴 , о ְ ֽ ϰ ϴ ISTH 2023 Congress(ȸ 2023 ȸ) ij Ʈÿ 24Ϻ 28ϱ ִ.
Ȳ
2023-06-26
|
|
|
|
|
[] 캴 ӻ迡 ʿѰ?
캴 ӻ Ű ο ġ ϴµ ʼ ̴. 캴 õ ӻ ȯ ǰ ڶ ϴ Դ. ȯ ִ
Ȳ
2023-06-21
|
|
|